Search results
Results from the WOW.Com Content Network
Management of depression is the treatment of depression that may involve a number of different therapies: medications, behavior therapy, psychotherapy, and medical devices.
This article needs to be updated. The reason given is: Many outdated sources and information (older than five years). Please help update this article to reflect recent events or newly available information. (July 2024) Medical condition Major depressive disorder Other names Clinical depression, major depression, unipolar depression, unipolar disorder, recurrent depression Sorrowing Old Man (At ...
John Henry Coatsworth (born September 27, 1940) is an American historian of Latin America and the former [1] provost of Columbia University. [2] From 2012 until June 30, 2019, Coatsworth served as Columbia provost. [1]
Depression; Lithograph of a person diagnosed with melancholia and strong suicidal tendency in 1892: Specialty: Psychiatry, psychology: Symptoms: Low mood, aversion to activity, loss of interest, loss of feeling pleasure
Recurrent brief depression (RBD) defines a mental disorder characterized by intermittent depressive episodes, not related to menstrual cycles in women, occurring between approximately 6–12 times per year, over at least one year or more fulfilling the diagnostic criteria for major depressive episodes (DSM-IV and ICD-10) except for duration in which RBD is less than 14 days (typically 5–7 ...
Psychotic depression, also known as depressive psychosis, is a major depressive episode that is accompanied by psychotic symptoms. [2] It can occur in the context of bipolar disorder or major depressive disorder. [2]
The Social Security Fairness Act cleared a key procedural hurdle Wednesday, soaring past the 60 votes it needs to advance by a vote of 73-27. This puts the legislation on a glide path toward final ...
The patient is rated by a clinician on 17 to 29 items (depending on version) scored either on a 3-point or 5-point Likert-type scale. For the 17-item version, a score of 0–7 is considered to be normal while a score of 20 or higher (indicating at least moderate severity) is usually required for entry into a clinical trial. [11]